Emily M. Leproust, Chief Executive Officer at Twist Bioscience Corp (TWST), sold 18,880 shares at $95.00 ($1.8M) on 2026-06-25, disclosed to the SEC on 2026-06-26.
Scheduled sale ($1.8M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TWST | SELL | 2026-09-25 | $923K | — | Filing → |
| TWST | SELL | 2026-09-23 | $279K | — | Filing → |
| TWST | SELL | 2026-09-21 | $56.3M | — | Filing → |